Companies / Financials
IVZ
Invesco
Asset Management & Custody Banks
Asset Management & Custody BanksAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health40
Growth37
Profitability3
Cash generationn/a
Balance sheetn/a
Dilution control81
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)14.2%Revenue growth (FY)5.1%Revenue CAGR (3y)1.8%Gross margin—Operating margin-10.9%Net margin-2.7%Free cash flow margin22.6%R&D / revenue—Stock comp / revenue1.3%Net debt / operating cash flow0.52xCurrent ratio—Diluted share count change-0.6%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $6.9B | $6.0B | $5.7B | $6.1B | $6.4B |
| Operating income | $1.8B | $1.3B | -$435M | $832M | -$696M |
| Net income | $1.4B | $684M | -$334M | $538M | -$175M |
| Operating cash flow | $1.1B | $703M | $1.3B | $1.2B | $1.5B |
| Capital expenditure | $109M | $193M | $164M | $69M | $84M |
| Free cash flow | $969M | $510M | $1.1B | $1.1B | $1.4B |
| Stock-based comp | $140M | $106M | $115M | $105M | $80M |
| Buybacks | $61M | $245M | $188M | $79M | $124M |
| Dividends | $308M | $335M | $358M | $372M | $377M |
| Cash | $1.9B | $1.2B | $1.5B | $986M | $1.0B |
| Total debt | $2.1B | $1.5B | $1.5B | $891M | $1.8B |
| Equity | $15.5B | $15.2B | $14.6B | $14.6B | $12.2B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.